Product Information
RIVASTIGMINE 3 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1666 per EA under NDC 33342009009. Its NADAC has been published 577 times since Jun 10, 2015.
Strength
3 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342009009
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203148On Market Since
9/2/2014
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 3 MG CAPSULE has been published 577 times since Jun 10, 2015, and over the history we have for it it has declined 89.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1666 per EA |
|---|---|
| All-time high | $1.6656 (Aug 12, 2015) |
| All-time low | $0.1451 (Jul 17, 2024) |
| 52-week high | $0.2053 |
| 52-week low | $0.1578 |
| Median price | $0.3273 |
| Average price | $0.4853 |
| Largest weekly change | -37.0% (Sep 20, 2017) |
| Weeks tracked | 577 |
| Tracking since | Jun 10, 2015 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 3 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.1666 per EA (NDC 33342009009), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 3 MG CAPSULE has declined 89.3%. It has been tracked across 577 weekly CMS publications since Jun 10, 2015.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 3 MG CAPSULE?
Since Jun 10, 2015, the NADAC for RIVASTIGMINE 3 MG CAPSULE has ranged from a low of $0.1451 (Jul 17, 2024) to a high of $1.6656 (Aug 12, 2015), with a median of $0.3273 per EA.
Are there cheaper alternatives to RIVASTIGMINE 3 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as RIVASTIGMINE 3 MG CAPSULE, but none are currently priced below it.
Who manufactures RIVASTIGMINE 3 MG CAPSULE?
RIVASTIGMINE 3 MG CAPSULE (NDC 33342009009) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification